These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 17205455)

  • 21. Interruption of antiretroviral treatment in HIV-infected patients with preserved immune function is associated with a low rate of clinical progression: a prospective study by AIDS Clinical Trials Group 5170.
    Skiest DJ; Su Z; Havlir DV; Robertson KR; Coombs RW; Cain P; Peterson T; Krambrink A; Jahed N; McMahon D; Margolis DM;
    J Infect Dis; 2007 May; 195(10):1426-36. PubMed ID: 17436222
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Seeking a cure for AIDS.
    Laurence J
    AIDS Read; 2008 May; 18(5):228, 234. PubMed ID: 18589476
    [No Abstract]   [Full Text] [Related]  

  • 23. Short communication: CD4 counts of HIV-infected pregnant women and their infected children--implications for PMTCT and treatment programmes.
    Lebon A; Bland RM; Rollins NC; Coutsoudis A; Coovadia H; Newell ML
    Trop Med Int Health; 2007 Dec; 12(12):1472-4. PubMed ID: 18076554
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stable pattern of HIV-1 subtype C Gag-specific T-cell responses coincides with slow rate of CD4 T-cell decline in HIV-infected Ethiopians.
    Tsegaye A; Ran L; Wolday D; Petros B; Nanlohy NM; Meles H; Girma M; Hailu E; Borghans J; Miedema F; van Baarle D
    AIDS; 2007 Jan; 21(3):369-72. PubMed ID: 17255746
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low-cost enumeration of CD4+ T cells using a density-based negative selection method (RosetteSep) for the monitoring of HIV-infected individuals in non-OECD countries.
    Bold A; Wurth R; Keller T; Trahorsch U; Voigt P; Schubert S; Sack U
    Cytometry A; 2008 Jan; 73(1):28-35. PubMed ID: 18061955
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Is the CD4 cell percentage a better marker of immunosuppression than the absolute CD4 cell count in HIV-infected patients with cirrhosis?
    Bongiovanni M; Gori A; Lepri AC; Antinori A; de Luca A; Pagano G; Chiodera A; Puoti M; Monforte Ad;
    Clin Infect Dis; 2007 Sep; 45(5):650-3. PubMed ID: 17683003
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficient thymopoiesis contributes to the maintenance of peripheral CD4 T cells during chronic human immunodeficiency virus type 2 infection.
    Gautier D; Beq S; Cortesão CS; Sousa AE; Cheynier R
    J Virol; 2007 Nov; 81(22):12685-8. PubMed ID: 17804512
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New BD FACSCount CD4 reagent system for simultaneous enumeration of percent and absolute CD4 T-lymphocytes in HIV-1-infected pediatric patients.
    Pattanapanyasat K; Sukapirom K; Kowawisatsut L; Thepthai C
    Cytometry B Clin Cytom; 2008; 74 Suppl 1():S98-106. PubMed ID: 18307252
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CD4 validation for the World Health Organization classification and clinical staging of HIV/AIDS in a developing country.
    Edathodu J; Ali B; Alrajhi AA
    Int J Infect Dis; 2009 Mar; 13(2):243-6. PubMed ID: 18945632
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human papilloma virus types in the oral and cervical mucosa of HIV-positive South African women prior to antiretroviral therapy.
    Richter KL; van Rensburg EJ; van Heerden WF; Boy SC
    J Oral Pathol Med; 2008 Oct; 37(9):555-9. PubMed ID: 18355174
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Liver cirrhosis in HIV-infected patients: prevalence, aetiology and clinical outcome.
    Castellares C; Barreiro P; Martín-Carbonero L; Labarga P; Vispo ME; Casado R; Galindo L; García-Gascó P; García-Samaniego J; Soriano V
    J Viral Hepat; 2008 Mar; 15(3):165-72. PubMed ID: 18233989
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predictors of clinical progression among HIV-1-positive patients starting HAART with CD4+ T-cell counts > or =200 cells/mm3.
    Lapadula G; Torti C; Maggiolo F; Casari S; Suter F; Minoli L; Pezzoli C; Di Pietro M; Migliorino G; Ouiros-Roldan E; Ladisa N; Sighinolfi L; Costarelli S; Carosi G;
    Antivir Ther; 2007; 12(6):941-7. PubMed ID: 17926648
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CD4+ cell count 6 years after commencement of highly active antiretroviral therapy in persons with sustained virologic suppression.
    Moore RD; Keruly JC
    Clin Infect Dis; 2007 Feb; 44(3):441-6. PubMed ID: 17205456
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of a single-platform microcapillary flow cytometer for enumeration of absolute CD4+ T-lymphocyte counts in HIV-1 infected Thai patients.
    Pattanapanyasat K; Phuang-Ngern Y; Lerdwana S; Wasinrapee P; Sakulploy N; Noulsri E; Thepthai C; McNicholl JM
    Cytometry B Clin Cytom; 2007 Sep; 72(5):387-96. PubMed ID: 17474130
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Epidemiology of primary drug resistance in chronically HIV-infected patients in Nordrhein-Westfalen, Germany, 2001-2005].
    Oette M; Kaiser R; Däumer M; Fätkenheuer G; Rockstroh JK; Knechten H; Mitrenga D; Beerenwinkel N; Sagir A; Pfister H; Häussinger D
    Dtsch Med Wochenschr; 2007 May; 132(18):977-82. PubMed ID: 17457780
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunization with an HIV-1 immunogen induces CD4+ and CD8+ HIV-1-specific polyfunctional responses in patients with chronic HIV-1 infection receiving antiretroviral therapy.
    Valor L; Navarro J; Carbone J; Rodríguez-Sáinz C; Gil J; López F; Fernández-Cruz E;
    Vaccine; 2008 May; 26(22):2738-45. PubMed ID: 18433946
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anticardiolipin antibodies in HIV infection are independently associated with antibodies to the membrane proximal external region of gp41 and with cell-associated HIV DNA and immune activation.
    Martinez V; Diemert MC; Braibant M; Potard V; Charuel JL; Barin F; Costagliola D; Caumes E; Clauvel JP; Autran B; Musset L;
    Clin Infect Dis; 2009 Jan; 48(1):123-32. PubMed ID: 19035778
    [TBL] [Abstract][Full Text] [Related]  

  • 38. WHO HIV clinical staging or CD4 cell counts for antiretroviral therapy eligibility assessment? An evaluation in rural Rakai district, Uganda.
    Kagaayi J; Makumbi F; Nakigozi G; Wawer MJ; Gray RH; Serwadda D; Reynolds SJ
    AIDS; 2007 May; 21(9):1208-10. PubMed ID: 17502733
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quality of life and immune activation in patients with HIV-infection.
    Schroecksnadel K; Sarcletti M; Winkler C; Mumelter B; Weiss G; Fuchs D; Kemmler G; Zangerle R
    Brain Behav Immun; 2008 Aug; 22(6):881-9. PubMed ID: 18261883
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CD38+CD8+ T-cells negatively correlate with CD4 central memory cells in virally suppressed HIV-1-infected individuals.
    Kolber MA
    AIDS; 2008 Oct; 22(15):1937-41. PubMed ID: 18784457
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.